Pilocarpine
intraperitoneally
rats
neuropathological sequelae
temporal lobe epilepsy
animal model
mechanisms
buildup
convulsive activity
pathways
operative
generalization
propagation
seizures
forebrain
study
effects of
manipulating
activity
gamma-aminobutyric acid
synaptic inhibition
substantia nigra
seizures
pilocarpine
rats
investigated
animals
pretreated
microinjections
isoniazid
inhibitor
activity
GABA-synthesizing enzyme
L-glutamic acid decarboxylase
substantia nigra pars reticulata
SNR
bilaterally
non-convulsant doses
pilocarpine
severe
motor limbic seizures
status epilepticus
Electroencephalographic
behavioral
monitoring
reduction
threshold
pilocarpine-induced convulsions
Morphological
frontal forebrain
sections
light microscopy
seizure-related damage
hippocampal
formation
thalamus
amygdala
olfactory cortex
substantia nigra
neocortex
pilocarpine
doses
Bilateral
intrastriatal
injections
isoniazid
seizures
pilocarpine
irreversible inhibitor
GABA transaminase
gamma-vinyl-GABA
D
L-4-amino-hex-5-enoic acid
SNR
bilaterally
suppressed
appearance
electrographic
behavioral seizures
pilocarpine
treatment
animals
occurrence
brain damage
Microinjections
gamma-vinyl-GABA
dorsal striatum
bilaterally
prevent
development
convulsions
pilocarpine
results
threshold
pilocarpine-induced seizures
rats
regulation
GABA-mediated synaptic inhibition
substantia nigra
